Download Release

About BIOCAD
BIOCAD is Russia’s leading innovative biotechnology company which
combines a world-class research and development center, ultramodern pharmaceutical and biotechnology manufacturing facilities,
and pre-clinical and clinical research infrastructure compliant with
international standards.
BIOCAD is one of the few world’s full-cycle drug development and
manufacturing companies, doing everything from new molecules
discovery and genetic engineering to large-scale commercial
manufacturing and marketing support. BIOCAD’s medicines are used
to treat the most complex health conditions, such as cancer, HIV and
Hepatitis C infections, multiple sclerosis and other disorders.
The company employs about 1000 people, 300 out of them scientists
and researchers. In 2014 BIOCAD’s sales tripled and reached $200
million, while total amount of long-term international contracts
exceeded half a billion US dollars. BIOCAD has subsidiaries in the US,
Brazil, China, India, Singapore, and other countries.